Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2017 (2017), Article ID 6848430, 13 pages
https://doi.org/10.1155/2017/6848430
Research Article

Growth Arrest-Specific 6 Enhances the Suppressive Function of CD4+CD25+ Regulatory T Cells Mainly through Axl Receptor

1Emergency Department, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou 325000, China
2Burns Institute, First Hospital Affiliated to the Chinese PLA General Hospital, Beijing 100048, China
3Department of Gastrointestinal Surgery, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou 325000, China

Correspondence should be addressed to Yong-Ming Yao; moc.anis@ff_c and Zhong-qiu Lu; moc.361@518046_qzl

Received 8 September 2016; Revised 7 November 2016; Accepted 5 December 2016; Published 8 February 2017

Academic Editor: Eugenio A. C. Silva

Copyright © 2017 Guang-ju Zhao et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. Y. Belkaid, “Regulatory T cells and infection: a dangerous necessity,” Nature Reviews Immunology, vol. 7, no. 11, pp. 875–888, 2007. View at Publisher · View at Google Scholar · View at Scopus
  2. S. Sakaguchi, T. Yamaguchi, T. Nomura, and M. Ono, “Regulatory T cells and immune tolerance,” Cell, vol. 133, no. 5, pp. 775–787, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. Y.-Y. Luan, C.-F. Yin, Q.-H. Qin et al., “Effect of regulatory T cells on promoting apoptosis of t lymphocyte and its regulatory mechanism in sepsis,” Journal of Interferon and Cytokine Research, vol. 35, no. 12, pp. 969–980, 2015. View at Publisher · View at Google Scholar · View at Scopus
  4. A. Alunno, M. Manetti, S. Caterbi et al., “Altered immunoregulation in rheumatoid arthritis: the role of regulatory T cells and proinflammatory Th17 cells and therapeutic implications,” Mediators of Inflammation, vol. 2015, Article ID 751793, 12 pages, 2015. View at Publisher · View at Google Scholar · View at Scopus
  5. J. A. Bluestone, J. H. Buckner, M. Fitch et al., “Type 1 diabetes immunotherapy using polyclonal regulatory T cells,” Science Translational Medicine, vol. 7, no. 315, Article ID 315ra189, 2015. View at Publisher · View at Google Scholar · View at Scopus
  6. S. Li, Q. Fan, S. He, T. Tang, Y. Liao, and J. Xie, “MicroRNA-21 negatively regulates treg cells through a TGF-β1/smad-independent pathway in patients with coronary heart disease,” Cellular Physiology and Biochemistry, vol. 37, no. 3, pp. 866–878, 2015. View at Publisher · View at Google Scholar · View at Scopus
  7. J. H. Esensten, D. Wofsy, and J. A. Bluestone, “Regulatory T cells as therapeutic targets in rheumatoid arthritis,” Nature Reviews Rheumatology, vol. 5, no. 10, pp. 560–565, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. L.-N. Jiang, Y.-M. Yao, and Z.-Y. Sheng, “The role of regulatory T cells in the pathogenesis of sepsis and its clinical implication,” Journal of Interferon and Cytokine Research, vol. 32, no. 8, pp. 341–349, 2012. View at Publisher · View at Google Scholar · View at Scopus
  9. J. H. M. van der Meer, T. van der Poll, and C. van't Veer, “TAM receptors, Gas6, and protein S: roles in inflammation and hemostasis,” Blood, vol. 123, no. 16, pp. 2460–2469, 2014. View at Publisher · View at Google Scholar · View at Scopus
  10. C. V. Rothlin and G. Lemke, “TAM receptor signaling and autoimmune disease,” Current Opinion in Immunology, vol. 22, no. 6, pp. 740–746, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. S. Scutera, T. Fraone, T. Musso et al., “Survival and migration of human dendritic cells are regulated by an IFN-α-inducible Axl/Gas6 pathway,” Journal of Immunology, vol. 183, no. 5, pp. 3004–3013, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. F. Alciato, P. P. Sainaghi, D. Sola, L. Castello, and G. C. Avanzi, “TNF-α, IL-6, and IL-1 expression is inhibited by GAS6 in monocytes/macrophages,” Journal of Leukocyte Biology, vol. 87, no. 5, pp. 869–875, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. T. D. Camenisch, B. H. Koller, H. S. Earp, and G. K. Matsushima, “A novel receptor tyrosine kinase, mer, inhibits TNF-α production and lipopolysaccharide-induced endotoxic shock,” Journal of Immunology, vol. 162, no. 6, pp. 3498–3503, 1999. View at Google Scholar · View at Scopus
  14. Q. Lu and G. Lemke, “Homeostatic regulation of the immune system by receptor tyrosine kinases of the Tyro 3 family,” Science, vol. 293, no. 5528, pp. 306–311, 2001. View at Publisher · View at Google Scholar · View at Scopus
  15. G. Lemke and C. V. Rothlin, “Immunobiology of the TAM receptors,” Nature Reviews Immunology, vol. 8, no. 5, pp. 327–336, 2008. View at Publisher · View at Google Scholar · View at Scopus
  16. A. Neubauer, A. Fiebeler, D. K. Graham et al., “Expression of axl, a transforming receptor tyrosine kinase, in normal and malignant hematopoiesis,” Blood, vol. 84, no. 6, pp. 1931–1941, 1994. View at Google Scholar · View at Scopus
  17. G.-J. Zhao, Z.-Q. Lu, L.-M. Tang et al., “Curcumin inhibits suppressive capacity of naturally occurring CD4 +CD25+ regulatory T cells in mice in vitro,” International Immunopharmacology, vol. 14, no. 1, pp. 99–106, 2012. View at Publisher · View at Google Scholar · View at Scopus
  18. D.-W. Wang, R.-B. Zhou, Y.-M. Yao et al., “Stimulation of α7 nicotinic acetylcholine receptor by nicotine increases suppressive capacity of naturally occurring CD4+CD25+ regulatory T cells in mice in vitro,” Journal of Pharmacology and Experimental Therapeutics, vol. 335, no. 3, pp. 553–561, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. G. Lemke and Q. Lu, “Macrophage regulation by Tyro 3 family receptors,” Current Opinion in Immunology, vol. 15, no. 1, pp. 31–36, 2003. View at Publisher · View at Google Scholar · View at Scopus
  20. Y.-J. Lee, J.-Y. Han, J. Byun et al., “Inhibiting Mer receptor tyrosine kinase suppresses STAT1, SOCS1/3, and NF-κB activation and enhances inflammatory responses in lipopolysaccharide-induced acute lung injury,” Journal of Leukocyte Biology, vol. 91, no. 6, pp. 921–932, 2012. View at Publisher · View at Google Scholar · View at Scopus
  21. H.-J. Park, J.-Y. Baen, Y.-J. Lee, Y.-H. Choi, and J. L. Kang, “The TAM-family receptor Mer mediates production of HGF through the RhoA-dependent pathway in response to apoptotic cells,” Molecular biology of the cell, vol. 23, no. 16, pp. 3254–3265, 2012. View at Publisher · View at Google Scholar · View at Scopus
  22. R. C. Gruber, A. K. Ray, C. T. Johndrow et al., “Targeted GAS6 delivery to the CNS protects axons from damage during experimental autoimmune encephalomyelitis,” The Journal of Neuroscience, vol. 34, no. 49, pp. 16320–16335, 2014. View at Publisher · View at Google Scholar · View at Scopus
  23. M. D. Giangola, W.-L. Yang, S. R. Rajayer, J. Nicastro, G. F. Coppa, and P. Wang, “Growth arrest-specific protein 6 attenuates neutrophil migration and acute lung injury in sepsis,” Shock, vol. 40, no. 6, pp. 485–491, 2013. View at Publisher · View at Google Scholar · View at Scopus
  24. Y.-J. Hung, C.-H. Lee, N.-F. Chu, and Y.-S. Shieh, “Plasma protein growth arrest-specific 6 levels are associated with altered glucose tolerance, inflammation, and endothelial dysfunction,” Diabetes Care, vol. 33, no. 8, pp. 1840–1844, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. G. Gasteiger and W. Kastenmuller, “Foxp3+ regulatory T-cells and IL-2: the Moirai of T-cell fates?” Frontiers in Immunology, vol. 3, article no. 179, 2012. View at Publisher · View at Google Scholar · View at Scopus
  26. A. S. McKee and E. J. Pearce, “CD25+CD4+ cells contribute to Th2 polarization during helminth infection by suppressing Th1 response development,” Journal of Immunology, vol. 173, no. 2, pp. 1224–1231, 2004. View at Publisher · View at Google Scholar · View at Scopus
  27. B. T. van den Brand, S. Abdollahi-Roodsaz, E. A. Vermeij et al., “Therapeutic efficacy of Tyro3, Axl, and Mertk tyrosine kinase agonists in collagen-induced arthritis,” Arthritis & Rheumatology, vol. 65, pp. 671–680, 2013. View at Google Scholar
  28. K. Nagata, K. Ohashi, T. Nakano et al., “Identification of the product of growth arrest-specific gene 6 as a common ligand for Axl, Sky, and Mer receptor tyrosine kinases,” The Journal of Biological Chemistry, vol. 271, no. 47, pp. 30022–30027, 1996. View at Publisher · View at Google Scholar · View at Scopus
  29. S. Sinha, J. Boysen, M. Nelson et al., “Targeted Axl inhibition primes chronic lymphocytic leukemia B cells to apoptosis and shows synergistic/additive effects in combination with BTK inhibitors,” Clinical Cancer Research, vol. 21, no. 9, pp. 2115–2126, 2015. View at Publisher · View at Google Scholar · View at Scopus